Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 15, 2001Journal of Clinical Oncology

2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology*

View Full Paper
Ask AI
Bookmark
Share

Authors

Robert C. BastRobert C. BastIntermountain HealthcarePRPeter M. RavdinThe University of Texas MD Anderson Cancer CenterDaniel F. HayesDaniel F. HayesIntermountain Healthcare

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bast et al. (2001) studied this question.

synapsesocial.com/papers/69fd3d8a7467cb4cde270a2bhttps://doi.org/10.1200/jco.2001.19.6.1865
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer.1990 · 595 citations
  2. 2Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry1997 · 57 citations
  3. 3c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast Cancer1994 · 965 citations
  4. 4HER-2/neu oncogene protein and prognosis in breast cancer.1989 · 584 citations